Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Evaluation of Effectiveness of Treatment Paradigm for Newly Diagnosed Type 2 Diabetes Patients in China (NEW2D)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2012 by China Cardiometabolic Registries.
Recruitment status was  Active, not recruiting
Sponsor:
Collaborators:
Bristol-Myers Squibb
VitalStrategic Research Institute
Information provided by (Responsible Party):
China Cardiometabolic Registries
ClinicalTrials.gov Identifier:
NCT01525693
First received: February 1, 2012
Last updated: February 13, 2013
Last verified: February 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: January 2014
  Estimated Primary Completion Date: October 2013 (Final data collection date for primary outcome measure)